China is relying on vaccines with lower efficacy rates. Photo: Xinhua
Explainer |
How China’s drive to develop its own state-of-the-art Covid vaccine is going
- The country has not authorised any mRNA vaccines, despite their proven benefits, a move many observers believe is down to the wish to develop its own version
- Currently a number of candidate vaccines made by Chinese firms are undergoing clinical trials
China is relying on vaccines with lower efficacy rates. Photo: Xinhua